MetLife (NYSE:MET) Price Target Raised to $96.00

MetLife (NYSE:MET) had its target price boosted by Barclays from $90.00 to $96.00 in a report issued on Monday,Benzinga reports. They currently have an overweight rating on the financial services provider’s stock.

A number of other brokerages also recently commented on MET. Wells Fargo & Company lifted their target price on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. TD Cowen increased their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Piper Sandler raised their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Jefferies Financial Group increased their target price on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. Finally, StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a research report on Wednesday, January 1st. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.00.

MetLife Trading Up 0.9 %

MET opened at $82.91 on Monday. The firm’s fifty day moving average price is $82.85 and its 200 day moving average price is $78.84. The stock has a market capitalization of $57.41 billion, a PE ratio of 16.72, a P/E/G ratio of 0.76 and a beta of 1.07. MetLife has a 12-month low of $64.61 and a 12-month high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be given a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.63%. MetLife’s dividend payout ratio is 43.95%.

Institutional Investors Weigh In On MetLife

A number of hedge funds have recently modified their holdings of MET. MeadowBrook Investment Advisors LLC boosted its stake in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. increased its position in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after buying an additional 186 shares during the period. Wolff Wiese Magana LLC raised its stake in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares in the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife in the third quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC grew its holdings in shares of MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 266 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.